Determination of clozapine and its major metabolites in human plasma and red blood cells by high-performance liquid chromatography with ultraviolet absorbance detection

Journal of Chromatography B: Biomedical Applications

Volumn 690, Issue 1-2, 1997, Pages 211-222

  Guitton, Claire ^a   Kinowski, Jean Marie ^a   Aznar, Regis ^a   Bressolle, Françoise ^a,b  

^a DEPARTMENT OF NEUROLOGY   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Clozapine; N Desmethylclozapine; N oxide

Indexed keywords

CLOZAPINE; DRUG METABOLITE;

ACCURACY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIQUID LIQUID EXTRACTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOZAPINE; DRUG STABILITY; ERYTHROCYTES; HUMANS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0031004166     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(96)00362-3     Document Type: Article

References (28)

1. D.E. Baldessarini and F.R. Frankenburg, N. Engl. J. Med., 324 (1981) 746.
2. J. Kane, G. Honigfeld, J. Singer, H. Meltzer and the Clozaril Collaborative Study Group, Arch. Gen. Psychiatr., 45 (1988) 789.
3. I. Creese, Trends Neurosci., 6 (1983) 479.
4. R. Stephens, Compr. Psychiatr., 31 (1990) 315.
5. G.M. Simpsons and T.A. Cooper, Am. J. Psychiatr., 135 (1978) 99.
6. P. Krupp and P. Barnes, Br. J. Psychiatr., 160 (1992) 38.
7. J. Idänpään-Heikkilä, E. Alhava, M. Ollkinoura and I. P. Palva, Eur. J. Clin. Pharmacol., 11 (1977) 193.
8. J.R. Calabrese, H.Y. Meltzer and P.J. Markovitz, J. Clin. Psychopharmacol., 10 (1990) 18.
9. S.L. McElroy, E.C. Dessain, H.G. Pope Jr., J.O. Cole, P.E. Keck, F.R. Frankenburg et al., J. Clin. Psychiatr., 52 (1991) 411.
10. R. Gauch and W. Michaelis, Farmaco, 26 (1978) 151.
11. K. Richtner, J. Chromatogr., 434 (1988) 465.
12. R. Heipertz, H. Pilz and W. Beckers, Arch. Toxicol., 37 (1977) 313.
13. V. Bondesson and L.H. Lindstrom, Psychopharmacology, 95 (1988) 472.
14. W. Zeren, L. Minglian, X. Peipei and Z. Yanlin, Biomed. Chromatogr., 1 (1986) 53.
15. C. Haring, C. Humpel, B. Auer, A. Saria, A. Barnas, W. Fleischhacker and H. Hinterhuber, J. Chromatogr., 428 (1988) 160.
16. J.P. Chovan and J.D. Vermeulen, J. Chromatogr., 494 (1989) 413.
17. D. Wilhelm and A. Kemper, J. Chromatogr., 525 (1990) 218.
18. M.J. Lovedahl, P.J. Perry and D.D. Miller, Ther. Drug Monitr. 13 (1991) 69.
19. H. Weigmann and C. Hiemke, J. Chromatogr., 583 (1992) 209.
20. M.C. Chung, S.K. Lin and W.H. Chang, J. Chromatogr., 613 (1993) 168.
21. O.V. Olesen and B. Poulsen, J. Chromatogr., 622 (1993) 39.
22. S.A. Volpicelli, F. Centorrino, P.R. Puopolo, J. Kando, F.R. Frankenburg, R.J. Baldessarini and J.G. Flood, Clin. Chem., 39 (1993) 1656.
23. R.N. Gupta, J. Chromatogr. B, 673 (1995) 311.
24. E.O. Fadiran, J. Leslie, M. Fossler and D. Young, J. Pharm. Biomed. Anal., 13 (1995) 185.
25. C. Humpel, C. Haring and A. Sana, J. Chromatogr., 491 (1989) 235.
26. United States Pharmacopoeia XXXIII, The United States Pharmacopeial Convention, Rockville, MD, 1994, p. 1929.
27. V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilveray, J.P. Skelly, A. Yacobi, T. Layloff, C.T. Viswanathan, C.E. Cook, R.D. McDowall, K.A. Pittman and S. Spector, J. Pharm. Sci., 81 (1992) 309.
28. M. Ackenheil, Psychopharmacology, 99 (1989) 32.